Theriva Biologics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Theriva Biologics, Inc. (TOVX) had Operating Lease, Weighted Average Discount Rate, Percent of 12.72% as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 12.72%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 12.63%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.93%.
- 2025-06-30: Operating Lease, Weighted Average Discount Rate, Percent 10.21%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 12.72% 10-Q · filed 2026-08-11 |
| 2026-03-31 | 12.63% 10-Q · filed 2026-05-05 |
| 2025-12-31 | 9.93% 10-K · filed 2026-03-12 |
| 2025-06-30 | 10.21% 10-Q · filed 2026-08-11 |
| 2025-03-31 | 10.36% 10-Q · filed 2026-05-05 |
| 2024-12-31 | 10.42% 10-K · filed 2026-03-12 |
| 2023-12-31 | 8.50% 10-K · filed 2024-03-25 |
| 2022-12-31 | 8.50% 10-K · filed 2023-03-30 |
| 2021-12-31 | 8.50% 10-K · filed 2022-03-16 |
| 2021-03-31 | 9.90% 10-Q · filed 2021-05-05 |
| 2020-12-31 | 9.90% 10-K · filed 2021-03-04 |
| 2020-09-30 | 9.90% 10-Q · filed 2020-11-10 |
| 2020-06-30 | 9.90% 10-Q · filed 2020-08-06 |
| 2020-03-31 | 9.90% 10-Q · filed 2020-05-05 |
| 2019-12-31 | 9.90% 10-K · filed 2020-02-20 |
| 2019-09-30 | 9.90% 10-Q · filed 2019-11-04 |
| 2019-06-30 | 9.90% 10-Q · filed 2019-08-08 |
| 2019-03-31 | 9.90% 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |